Turnspire Capital Partners has acquired Pharmachem Innovations, enhancing its portfolio in the lucrative nutraceuticals industry.

Target Company Information

Turnspire Capital Partners LLC has successfully completed the acquisition of Pharmachem Innovations, LLC, the former nutraceuticals division of Ashland Inc. This acquisition positions Pharmachem as a leading provider of proprietary nutrition ingredients and custom formulation services, offering a comprehensive portfolio of active ingredients and formulation aids tailored for nutritional product companies. With a dedicated workforce of approximately 500 employees, Pharmachem operates across four production facilities located in New Jersey, Utah, and Tamaulipas, Mexico.

Pharmachem excels in custom formulation and contract manufacturing, managing the end-to-end process from formula design and ingredient sourcing to final product manufacturing. The company’s expertise in the nutraceuticals industry underscores its commitment to innovation and high-quality standards.

Industry Overview

The nutraceuticals industry has seen significant growth, driven by increasing health awareness and consumption of dietary supplements. Market trends indicate a robust demand for nutrition products, particularly in de